These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 15328199)

  • 21. Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer.
    Lubbe WJ; Zhou ZY; Fu W; Zuzga D; Schulz S; Fridman R; Muschel RJ; Waldman SA; Pitari GM
    Clin Cancer Res; 2006 Mar; 12(6):1876-82. PubMed ID: 16551873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of reversion-inducing cysteine-rich protein with kazal motifs (RECK) and extracellular matrix metalloproteinase inducer (EMMPRIN), with MMP-2, MMP-9, and survival in colorectal cancer.
    van der Jagt MF; Sweep FC; Waas ET; Hendriks T; Ruers TJ; Merry AH; Wobbes T; Span PN
    Cancer Lett; 2006 Jun; 237(2):289-97. PubMed ID: 16046057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
    Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion.
    Liu LT; Chang HC; Chiang LC; Hung WC
    Cancer Res; 2003 Jun; 63(12):3069-72. PubMed ID: 12810630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of matrix metalloproteinase regulator, RECK, and its clinical significance in osteosarcoma.
    Xu J; Wu S; Shi X
    J Orthop Res; 2010 Dec; 28(12):1621-5. PubMed ID: 20973064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of reversion-inducing cysteine-rich protein with Kazal motifs expression in resected pathologic stage IIIA N2 non-small-cell lung cancer.
    Takenaka K; Ishikawa S; Yanagihara K; Miyahara R; Hasegawa S; Otake Y; Morioka Y; Takahashi C; Noda M; Ito H; Wada H; Tanaka F
    Ann Surg Oncol; 2005 Oct; 12(10):817-24. PubMed ID: 16132376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship between expression of matrix metalloproteinase (MMP-9) and tumor angiogenesis, cancer cell proliferation, invasion, and metastasis in invasive carcinoma of cervix].
    Jiang ZQ; Zhu FC; Qu JY; Zheng X; You CL
    Ai Zheng; 2003 Feb; 22(2):178-84. PubMed ID: 12600296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues].
    Liu R; Pu DM; Cheng YX; Yin L
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1326-9. PubMed ID: 17727777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RECK negatively regulates matrix metalloproteinase-9 transcription.
    Takagi S; Simizu S; Osada H
    Cancer Res; 2009 Feb; 69(4):1502-8. PubMed ID: 19208844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
    Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
    J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
    Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
    Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical impact of matrix metalloproteinase-7 mRNA expression in the invasive front and inner surface of tumor tissues in patients with colorectal cancer.
    Higashiguchi T; Hotta T; Takifuji K; Yokoyama S; Matsuda K; Tominaga T; Oku Y; Yamaue H
    Dis Colon Rectum; 2007 Oct; 50(10):1585-93. PubMed ID: 17676380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of platelet-derived endothelial cell growth factor correlates with good prognosis in patients with colorectal carcinoma.
    Saito S; Tsuno N; Nagawa H; Sunami E; Zhengxi J; Osada T; Kitayama J; Shibata Y; Tsuruo T; Muto T
    Cancer; 2000 Jan; 88(1):42-9. PubMed ID: 10618604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of membrane-anchored matrix metalloproteinase inhibitor reversion inducing cysteine rich protein with Kazal motifs in murine cell lines.
    Takagi S; Hoshino Y; Osaki T; Okumura M; Fuginaga T
    Exp Oncol; 2007 Mar; 29(1):30-4. PubMed ID: 17431385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RECK--a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer.
    Clark JC; Thomas DM; Choong PF; Dass CR
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):675-83. PubMed ID: 17828469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
    Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Harris AL;
    J Clin Oncol; 2006 Sep; 24(26):4301-8. PubMed ID: 16896001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer.
    Zinzindohoué F; Lecomte T; Ferraz JM; Houllier AM; Cugnenc PH; Berger A; Blons H; Laurent-Puig P
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):594-9. PubMed ID: 15701845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer.
    Zhang L; Shi J; Feng J; Klocker H; Lee C; Zhang J
    Prostate Cancer Prostatic Dis; 2004; 7(4):327-32. PubMed ID: 15356679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
    Pesta M; Holubec L; Topolcan O; Cerna M; Rupert K; Holubec LS; Treska V; Kormunda S; Elgrova L; Finek J; Cerny R
    Anticancer Res; 2005; 25(5):3387-91. PubMed ID: 16101153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.